Qube Research & Technologies (QRT)
CAI

Qube Research & Technologies (QRT)’s Caris Life Sciences CAI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.04M Buy
226,878
+39,398
+21% +$705K ﹤0.01% 1742
2026
Q1 		$3.35M Sell
187,480
-19,513
-9% -$426K ﹤0.01% 1872
2025
Q4 		$5.58M Buy
206,993
+174,241
+532% +$4.91M 0.01% 1706
2025
Q3 		$991K Buy
32,752
+24,998
+322% +$797K ﹤0.01% 2516
2025
Q2 		$207K Buy
+7,754
New +$209K ﹤0.01% 2903

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Qube Research & Technologies (QRT)'s CAI Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Caris Life Sciences (CAI) stake by 21% in Q2 2026, buying an estimated $705K and bringing the position to 226,878 shares worth $4.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1742.

Qube Research & Technologies (QRT) first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.58M in Q4 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Qube Research & Technologies (QRT) held 226,878 shares of Caris Life Sciences worth $4.04M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 39,398 Caris Life Sciences shares in Q2 2026, an estimated $705K.
  • Caris Life Sciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1742 holding.
  • Qube Research & Technologies (QRT) first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Qube Research & Technologies (QRT)'s Caris Life Sciences position peaked at $5.58M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.